Found: 9
Select item for more details and to access through your institution.
Sensitive multiplexed analysis of kinase activities and activity-based kinase identification.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 10, p. 933, doi. 10.1038/nbt.1566
- By:
- Publication type:
- Article
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0111840
- By:
- Publication type:
- Article
Regulation of Brown Fat Adipogenesis by Protein Tyrosine Phosphatase 1B.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016446
- By:
- Publication type:
- Article
Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule.
- Published in:
- ChemBioChem, 2021, v. 22, n. 12, p. 2107, doi. 10.1002/cbic.202100047
- By:
- Publication type:
- Article
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158888
- By:
- Publication type:
- Article
Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A687V EZH2 is a gain-of-function mutation found in lymphoma patients
- Published in:
- FEBS Letters, 2012, v. 586, n. 19, p. 3448, doi. 10.1016/j.febslet.2012.07.066
- By:
- Publication type:
- Article
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
- Published in:
- Nature Chemical Biology, 2012, v. 8, n. 11, p. 890, doi. 10.1038/nchembio.1084
- By:
- Publication type:
- Article